Eugia US LLC has issued a voluntary recall for 45,250 vials of Acyclovir Sodium Injection 1,000 mg per 20 mL (50 mg/mL). This prescription medication is being recalled after a customer complaint identified dark particles inside a vial. No incidents or injuries have been reported to date. This medication was manufactured in India and the United States and distributed nationwide in the USA by AuroMedics Pharma LLC.
Injecting a product containing particulate matter can lead to serious health complications, including local inflammation, irritation, or blockages in the blood vessels. These blockages can travel to the heart, lungs, or brain, potentially causing a stroke or other life-threatening conditions.
Manufacturer-coordinated return
Quantity: 45,250 vials. Rx only. Distributed by AuroMedics Pharma LLC.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.